OpenAI launches GPT-Rosalind, an AI model for life sciences research, including drug discovery, as a research preview for customers such as Moderna and Amgen
OpenAI announced a new series of AI models built to help life sciences researchers work faster.
Axios Megan Morrone
Related Coverage
- Introducing GPT-Rosalind for life sciences research OpenAI
- OpenAI to rival Google's AlphaFold with new AI model for life sciences research Silicon Republic · Laura Varley
- OpenAI launches GPT-Rosalind, a specialised AI model for drug discovery and life sciences research The Next Web · Ana Maria Constantin
- OpenAI's Biology Model Is Not a Lab Breakthrough. It Is an Access Strategy. Implicator.ai · Maria Garcia
- OpenAI Launches GPT-Rosalind: Its First Life Sciences AI Model Built to Accelerate Drug Discovery and Genomics Research MarkTechPost · Asif Razzaq
- OpenAI starts offering a biology-tuned LLM Ars Technica · John Timmer
- OpenAI goes after Google DeepMind's turf with a new biology-focused AI model: GPT-Rosalind Neowin · Karthik Mudaliar
- OpenAI's GPT-Rosalind marks rise of science-first AI models The Deep View · Jason Hiner
- OpenAI debuts GPT-Rosalind, a new limited access model for life sciences, and broader Codex plugin on Github VentureBeat · Carl Franzen
- OpenAI Takes on Google With New AI Model Aimed at Drug Discovery Bloomberg · Rachel Metz
- OpenAI debuts a life sciences AI model, entering crowd of tech giants selling to pharma Endpoints News · Andrew Dunn
- OpenAI Targets Pharma Giants With Purpose-Built AI Model PYMNTS.com
- GPT-Rosalind for life sciences research Hacker News
- OpenAI launches GPT-Rosalind, a reasoning model built for life sciences research The Decoder · Matthias Bastian
- OpenAI is launching a specialized AI model for drug discovery and life sciences research Quartz · Cris Tolomia
- OpenAI Unveils GPT-Rosalind: New AI Model Targeting Pharmaceutical Research Acceleration Blockonomi · Trader Edge
- OpenAI Starts Offering a Biology-Tuned LLM Slashdot · BeauHD
Discussion
-
@andrewe_dunn
Andrew Dunn
on x
NEW: OpenAI is the latest tech giant to move into biopharma, launching Thursday GPT-Rosalind, a life sciences-tailored version of its LLM Trails behind the very similar launch of Anthropic's Claude for Life Sciences by ~5 months. More here: https://endpoints.news/...
-
@andrewe_dunn
Andrew Dunn
on x
All of a sudden, it's a crowded space of tech players looking to work with and sell to biopharma OpenAI's GPT-Rosalind Nvidia's BioNeMo Anthropic's Claude for Life Sci AWS' Amazon Bio Discovery (launched earlier this week) Edison Scientific Phylo & more that I'm surely missing
-
@bowang87
Bo Wang
on x
It is clear that every frontier AI lab will have dedicated frontier models for biology and drug discovery 🔥 Great time to be working on AI &Bio ! Can't wait to see what GPT-Rosalind can unlock for drug discovery!
-
@sporadica
@sporadica
on x
i like it when the big labs release tools specifically for accelerating scientific research, instead of just more addictive chatbots good release
-
@gdb
Greg Brockman
on x
Announcing GPT-Rosalind, our frontier model for life science research. This model is a step towards one of our most important goals — accelerating science and improving human outcomes. Excited to work with many amazing partners on deploying and improving this model. [image]
-
@benedictk__
Benedict Kerres
on x
GPT-Rosalind. We may be too quiet about this but we have a model for biology and drug discovery now. It's very cool and the people working on it are amazing. Super happy we get to do this and tackle very hard problems.
-
@deanwball
Dean W. Ball
on x
Available to “qualified customers.” As I wrote after Mythos, expect more models to have staggered releases, often exclusive to large firms and governments at first, due to a combination of safety reasons (biorisk in this case) and compute constraints.
-
@deanwball
Dean W. Ball
on x
It is also interesting that OpenAI is de-emphasizing safety concerns here, not mentioned at all in the tweets and only lightly discussed in the blog post. One imagines that if Anthropic had trained a similar model, they'd be way more “risk-forward.” It's not obvious to me which…
-
@omearabrian
Brian O'Meara
on bluesky
OpenAI is releasing a model “tuned” for science. They say they measured performance for “phylogenetic interpretation of DNA sequences” among other things. — My guess is NJ but bad. — My fear is essentially some real software running without attribution. But we'll all see...…
-
@alleninstitute.org
@alleninstitute.org
on bluesky
We're proud to be a launch partner for OpenAI's GPT-Rosalind, a new model designed to support life sciences research. — This collaboration is part of our broader effort to explore how AI can accelerate scientific discovery. — 🔗 https://openai.com/index/introducing- gpt-rosali…
-
r/singularity
r
on reddit
Introducing GPT-Rosalind for life sciences research